MedPath
HSA Approval

LATA-T LATANOPROST & TIMOLOL EYE DROPS 0.005% & 0.5% w/v

SIN17071P

LATA-T LATANOPROST & TIMOLOL EYE DROPS 0.005% & 0.5% w/v

LATA-T LATANOPROST & TIMOLOL EYE DROPS 0.005% & 0.5% w/v

August 27, 2024

APEX PHARMA MARKETING PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantAPEX PHARMA MARKETING PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

SOLUTION, STERILE

OPHTHALMIC

Medical Information

S01ED51

Manufacturer Information

APEX PHARMA MARKETING PTE. LTD.

RAFARM S.A.

Active Ingredients

Latanoprost

0.005%w/v

Latanoprost

Timolol Maleate equivalent to Timolol

0.5%w/v

Timolol

Documents

Package Inserts

Lata-T PI Aug 2024.pdf

Approved: August 27, 2024

Download

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

LATA-T LATANOPROST & TIMOLOL EYE DROPS 0.005% & 0.5% w/v - HSA Approval | MedPath